The pharmacodynamics of 4-(p-chlorophenylthio)butanol (W-2719) in humans.
4-(p-Chlorophenylthio)butanol (W-2719) is absorbed, metabolized and excreted when administered orally to human volunteers. The butyrate (W-2718) and the acetate (W-2683) metabolites were found in plasma with W-2683 being the major biotransformation product and detectable seven days after administration with an apparent half-life of 33.2 h. p-Chlorothiophenol appeared to be the major biotransformation product in urine and was detectable through day 6. As in plasma, the other major biotransformation product was W-2683, which was again detectable through day 7 and had a t 1/2 in urine of 40.8 h. The minor metabolite found in urine was W-2718. No W-2719 was found in either plasma or urine after oral administration.
D000328:Adult; D001711:Biotransformation; D000440:Butanols / Q000378:metabolism*; D006207:Half-Life; D006636:Histamine Release / Q000187:drug effects*; D006801:Humans; D007700:Kinetics; D008297:Male
D000440:Butanols